B
Bull
Bull · 25%ESTA
$56.20
情境價格
$70.640
-1.144 (-1.62%)收盤時
Loading chart…
- High
- 72.165
- Open
- 71.330
- VWAP
- 71.05
- Vol
- 285.95K
- Mkt Cap
- 1.21B
- Low
- 70.356
- Amount
- 20.32M
- EV/EBITDA, TTM
- -144.66
Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers.
AI analysis of Establishment Labs Holdings Inc (ESTA)
holdEstablishment Labs Holdings Inc is currently a hold. The stock is priced at $70.64, significantly below analyst price targets of $92 and $105, indicating potential upside. However, the RSI is at a low 23.939, suggesting the stock is oversold, which could lead to further declines in the short term. The company reported a strong Q2 2026 revenue of $67.5 million, a 31.7% year-over-year increase, but remains unprofitable with a net income loss of $11.7 million in Q2 2026. The main risk is the high insider selling activity, which has increased by 141.15% over the last month, indicating potential lack of confidence from insiders.
Analyst Ratings (3)
+17.33% upside
Buy
3 Buy
0 Hold
0 Sell
Current: 70.64
最低
75.00
平均
82.88
最高
90.00
Citi
Buy
$92
2026-08-13
Citi
2026-08-13
目標價
$92
Buy
Canaccord
Buy
$105
2026-08-07
Canaccord
2026-08-07
目標價
$105
Buy
Mizuho
Outperform
$105
2026-07-15
Mizuho
2026-07-15
目標價
$105
Outperform
Citi
Neutral
$92
2026-07-08
Citi
2026-07-08
目標價
$92
Neutral
BTIG
Buy
$90
2026-05-07
BTIG
2026-05-07
目標價
$90
Buy
估值指標
The current forward P/E ratio for Establishment Labs Holdings Inc (ESTA) is 0.00, compared to its 5-year average forward P/E of -28.68.
Alphio AI Price Scenarios for ESTA
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Whales holding ESTA
事件時間軸
資訊
6.508-18CNBCJim Cramer's Insights on Five Stocks
6.008-13CNBCLatest Wall Street Rating Updates
8.508-12NewsfilterConexeu Sciences Targets Regenerative Medicine Market with Innovative Platform
9.508-06seekingalphaEstablishment Labs Reports Strong Q2 2026 Earnings with Raised Guidance
- 9.508-06seekingalpha
Establishment Labs Q2 Earnings Beat Expectations
ESTA FAQ — answered by Alphio AI
Establishment Labs Holdings Inc. is Costa Rica-based medical technology and aesthetics company that is focused on women's health reconstruction market. The Company is engaged in the designing, developing, manufacturing and marketing of product portfolio consisting of silicone-filled breast and body shaping implants. The main activities are conducted at two manufacturing facilities in Costa Rica including Motiva Implants brand sold in over 80 countries globally through a combination of distributors and direct sales to customers. It operates in the Healthcare sector (ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUP industry).
Establishment Labs Holdings Inc is currently a hold. The stock is priced at $70.64, significantly below analyst price targets of $92 and $105, indicating potential upside. However, the RSI is at a low 23.939, suggesting the stock is oversold, which could lead to further declines in the short term. The company reported a strong Q2 2026 revenue of $67.5 million, a 31.7% year-over-year increase, but remains unprofitable with a net income loss of $11.7 million in Q2 2026. The main risk is the high insider selling activity, which has increased by 141.15% over the last month, indicating potential lack of confidence from insiders.
3 analysts cover ESTA: 3 rate it Buy, 0 Hold and 0 Sell. The average price target is 82.88.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。